Anti-TNF-α agents play a significant part in therapy of various inflammatory disorders such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, juvenile idiopathic arthritis, ulcerative colitis, Crohn’s disease, and sarcoidosis [14, 28–33]. This evidence concerns the gene TNF and sarcoidosis.